FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 18:36:06 10/05/2024 BST | ||
| 0.57 EUR | +1.79% |
|
| Current month | -51.69% | ||
| 1 month | -58.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 0.57 | +1.79% | 0 |
| 09/05/24 | 0.56 | -12.50% | 0 |
| 08/05/24 | 0.64 | -5.88% | 0 |
| 07/05/24 | 0.68 | 0.00% | 0 |
| 06/05/24 | 0.68 | +25.93% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 06:36 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK0P16 |
| ISIN | DE000UK0P167 |
| Date issued | 12/04/2022 |
| Strike | 391.1 $ |
| Maturity | Unlimited |
| Parity | 126.47 : 1 |
| Emission price | 4.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.24 € |
|---|---|
| Lowest since issue | 0.43 € |
| Spread | 0.02 € |
| Spread % | 3.33% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
